Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 6.
Published in final edited form as: Neuroradiology. 2019 Jan 24;61(6):643–650. doi: 10.1007/s00234-019-02167-3

Assessment of Quantitative Methods for Enhancement Measurement on Vessel Wall Magnetic Resonance Imaging Evaluation of Intracranial Atherosclerosis

Matthew D Alexander 1,2, Adam de Havenon 3, Seong-Eun Kim 4, Dennis L Parker 5, Joseph S McNally 6
PMCID: PMC8022353  NIHMSID: NIHMS1684066  PMID: 30675639

Abstract

INTRODUCTION:

Quantitative measures of vessel wall magnetic resonance imaging (vwMRI) for the evaluation of intracranial atherosclerotic disease (ICAD) offers standardization not available with previously used qualitative approaches that may be difficult to replicate.

METHODS:

vwMRI studies performed to evaluate ICAD that had caused a stroke were analyzed. Two blinded reviewers qualitatively rated culprit lesions for the presence of enhancement on T1 DANTE SPACE images. At least 3 months later, quantitative analysis was performed of the same images, comparing lesion enhancement to reference structures. Cohen’s kappa and intraclass correlation coefficients were calculated to assess agreement. Ratios of enhancement of lesions to references were compared to qualitative ratings.

RESULTS:

Studies from 54 patients met inclusion criteria. A mean of 49 (90.7%) lesions were qualitatively rated as enhancing, with good inter-rater agreement (κ=0.783). Among reference structure candidates, low infundibulum demonstrated the highest inter-rater agreement on pre- and post-contrast imaging. The ratio of percentage increase in plaque signal following contrast to the same measure in low infundibulum demonstrated the highest agreement with qualitative assessment, with highest agreement seen with a ratio of 0.8 set as a threshold (κ=0.675).

CONCLUSION:

Quantitative metrics can yield objective data to better standardize techniques and acceptance of vwMRI evaluation of ICAD. The low infundibulum had the highest inter-rater agreement on both pre- and post-contrast images and is best suited as a normally enhancing reference structure. Such quantitative techniques should be implemented in future research of vwMRI for the evaluation of ICAD.

INTRODUCTION

Vessel wall magnetic resonance imaging (vwMRI) techniques are earning growing acceptance for evaluation of intracranial atherosclerotic disease (ICAD), expanding understanding by allowing visualization of vessel walls themselves utilizing black blood techniques such as delay alternating with nutation for tailored excitation (DANTE).[16] Current variability among acquisition and interpretation techniques hinders wider applicability and acceptance.[715] To better validate and standardize VWI techniques, particularly with respect to ICAD analysis, quantitative assessment can help define what constitutes enhancement. This study assesses quantitative techniques for the interpretation of vwMRI studies of ICAD, which incorporate several references structures also evaluated in this study, comparing quantitative metrics against qualitative ratings more commonly employed in prior vwMRI studies. In order to better standardize techniques as VWI studies become more widespread in clinical use and undergo further investigation, such quantitative metrics should be utilized when possible.

vwMRI techniques utilize flow suppression techniques to detect vessel wall pathology. This has led to novel evaluation of a host of diseases throughout the body.[3] Specifically, vwMRI has emerged as an important tool for evaluation of ICAD.[16,2,3,1] When analyzing ICAD with vwMRI, multiple lesion traits can be assessed quantitatively, including plaque enhancement, stenosis, presence of intraplaque hemorrhage, and pattern of remodeling. Plaque enhancement is an important trait that is distinctly prone to variability in interpretation that introduce error.[715,17,18,3,1923] To mitigate such variability, quantitative techniques are needed to allow standardization that can improve repeatability and applicability of findings. This study describes and evaluates such an approach to ICAD plaque enhancement that we hypothesize agrees well with currently utilized qualitative VWI interpretation techniques.

To properly quantify the degree of ICAD plaque enhancement on vwMRI, reliable reference structures that normally enhance can aid assessment.[24] Among previous investigations of vessel wall enhancement on vwMRI, some describe no methodology for comparison against reference control structures.[7,8,13] Other investigations have utilized non-enhancing tissues subject to the blood-brain barrier, most commonly gray matter, less commonly ventricles.[15,11,14] Others have compared normal vessel segments.[9] To address these previous limitations, this study also investigates normal vessels and multiple different structures that normally enhance following contrast administration to evaluate them as reference structures by virtue of their enhancement characteristics and inter-rater agreement.[25] Such information can help validate references so that future research can better standardize interpretation techniques, lending to more widely applicable results. Finally, to provide context for the methods examined in this study against the existing vwMRI literature, the various quantitative measures are compared against a previously used binary qualitative analysis. Many of the quantitative or semi-quantitative techniques reported in prior research are robust and effective. Indeed, techniques employed as described below correspond with those reported in some of this prior work. However, heterogeneity limits progress in this field, and quantitative techniques can increase consistency and move this field of study forward.

METHODS

According to an IRB-approved protocol, prospectively maintained records were queried to perform retrospective analysis of patients at a major academic medical center undergoing vwMRI during evaluation of new ischemic stroke. We included patients who had vwMRI within 14 days of their index stroke and who were determined to have ICAD-related stroke. An experienced vascular neurologist (AD) adjudicated the stroke mechanism. Patients with the following were excluded: bilateral stroke or stroke in multiple vascular distributions, >50% extracranial stenosis of an artery proximal to the stroke parent artery (e.g. right carotid stenosis >50% in a patient with a right MCA stroke), stroke DWI lesion diameter <1.5mm or lack of multiple infarctions if <1.5mm, prior diagnosis of atrial fibrillation or atrial fibrillation on standard-of-care 30 day mobile cardiac telemetry, hypercoaguable disorders, chronic anticoagulation, and uncommon causes of stroke (eg. vasculitis, CADASIL). Patients with incomplete or nondiagnostic vwMRI studies were excluded.

All images were acquired on Siemens (Erlangen, Germany) 3T MRI scanners (Prisma, Trio, or Verio) with dedicated head coils. Protocol details are provided in Table 1. Two neuroradiologists were blinded to diffusion and clinical data and instructed to analyze the arterial tree to which the new infarct was referable. The reviewing radiologists were instructed which parent arteries to assess after these were determined by a treating neurologist based on available clinical data and MRI findings. Reviewing images in the axial plane in which they were obtained, each reviewer identified the most likely culprit lesion in the stroke parent artery and qualitatively rated it as enhancing or not. Each culprit lesion, defined as the single likely source of downstream infarction, was determined by each reviewer and confirmed to be the same lesion for each patient. While consensus was established for which culprit lesion to assess, scores were blinded between reviewers. Assessment was repeated for the culprit plaques by the same reviewers at least three months later for quantitative analysis. Patients for whom multiple lesions could potentially be considered the culprit, i.e. multiple lesions upstream to an infarction, were excluded from analysis to reduce potential bias. Maximum voxel signal intensity values for the same plaques were noted on 3D T1-weighted SPACE with DANTE flow suppression pre- and post-contrast.[6] Figure 1 demonstrates a sequence diagram for these acquisitions. For each variable measured, the mean of three data points was computed after obtaining the maximum single-voxel intensity values at each site of interest. The same normal reference vessel was also evaluated by each reviewer. If a contralateral analogue with normal appearance was present, this vessel was evaluated. In cases involving contralateral disease or the basilar artery, the nearest normal arterial wall segment was interrogated.

Table 1:

T1 DANTE Imaging Parameter

Echo time (ms) 21
Repetition time (ms) 800
Flip Angle (degrees) 10
Field of view (cm) 18x18
Acquisition Matrix 384x384
Slice thickness (mm, after interpolation) 0.5
In-plane resolution (mm) 0.46 x 0.46
DANTE preparation time (ms) 150
Number of averages 1.4
TSE factor 62
Acquisition time per slice (s) 1.85
# of slices (after interpolation) 128
Bandwidth 789
Total Acquisition Time (min) 6:30

Figure 1.

Figure 1.

Sequence diagram for 3D DANTE T1W SPACE sequence, which consists of 150 trains of DANTE module followed by 3D T1W SPACE readouts.

Structures expected to normally enhance were also measured, including the mid infundibulum, defined as the midway point between the inferior margin of the hypothalamus and the upper margin of the pituitary gland; low infundibulum, defined as the lowest segment of the infundibulum distinguishable from the pituitary gland; choroid plexus in a lateral ventricle; cavernous sinus, measured at an intravascular site seen on post-contrast images; and muscle, measured in the temporalis muscle with signal medial to the mid-belly fibrous band of the muscle.[25] Sample regions of interest for each of these structures, as well as the intensity measured at each site, are presented in Figure 2.

Figure 2.

Figure 2.

Representative images of structures analyzed and intensities recorded before and after administration of contrast: (A, B) symptomatic left MCA ICAD plaque, (C, D) normal right MCA wall segment, (E, F) low infundibulum, (G, H) mid infundibulum, (I, J) choroid plexus, (K, L) cavernous sinus, (M, N) temporalis muscle.

Descriptive statistics were obtained to summarize patient and lesion characteristics. Cohen’s kappa and intraclass correlation coefficients (ICC) were calculated for binary and continuous variables, respectively, to assess agreement between interrogated methods, including inter-rater agreement for the initially obtained qualitative assessments, subsequently obtained quantitative methods, and comparison between quantitative and qualitative methods. Additionally, degree of stenosis measured on post-contrast 3D T1-weighted SPACE with DANTE images was calculated according the WASID technique using the following formula, [1 - (diameter at stenosis / diameter normal segment)] x 100.[26,27] Stenosis was measured at the site of the most severe stenosis, and normal segment was measured at the nearest proximal normal artery; if the proximal artery was diseased, a distal normal segment was chosen.[26,27]

Multiple methods were employed to quantitatively assess enhancement. For all interrogated structures, percentage increase in enhancement was measured according to the following formula, (post-contrast mean – pre-contrast mean)/pre-contrast mean. The ratios of plaque signal change to signal change in the various reference structures assessed were calculated. Optimal thresholds were determined by calculating all possible ratios from 0.3–1.5 for each combination interrogated. Statistics were performed using Stata version 15 (College Station, TX).

RESULTS

Studies from 54 patients met inclusion criteria. Mean time to vwMRI after diagnosis of infarct was 7 days. Patient demographics and lesion characteristics are summarized in Table 2. On qualitative analysis, a mean of 49 (90.7%) lesions were scored as demonstrating enhancement, with good inter-rater agreement (κ=0.783). Mean stenosis was 53.8% (±23.2%). 45 (83.3%) lesions had >25% stenosis, 32 (59.3%) had >50% stenosis, and 9 (16.7%) had >75% stenosis. 2 (3.7%) vessels were occluded, and 13 (24.1%) had stenosis ≥70%. ICC to measure inter-rater agreement for stenosis was (ICC=0.620).

Table 2:

Demographic and Lesion Characteristics

Mean Age (Years) 62.8 (±16.2, IQR 55.0–74.7)
Race
Caucasian 42 (77.8%)
Latino 5 (9.3%)
Native American 4 (7.4%)
Pacific Islander 3 (5.6%)
Male Gender 33 (61.1%)
Stroke Parent Artery
Internal Carotid 6 (11.1%)
Middle Cerebral 18 (33.3%)
Anterior Cerebral 2 (3.7%)
Vertebral 14 (25.9%)
Basilar 10 (18.5%)
Posterior Cerebral 4 (7.4%)
Tandem Lesions 32 (59.3%)
Branch Point Lesions 12 (22.2%)
Mean Stenosis 53.8% (±23.2%)
Qualitative Enhancement 49 (90.7%)

Results summarizing evaluation of reference structures (signal measurement characteristics and ICC as a measure of inter-rater agreement) are summarized in Table 3. Normal vessel segments demonstrated no substantial enhancement, with mean post-contrast values 112% of pre-contrast values. ICAD plaques demonstrated mean signal increase to 225% of pre-contrast values. Among normally enhancing structures, change in the cavernous sinus was most robust. Muscle demonstrated the lowest degree of enhancement. When comparing inter-rater correlation among the interrogated reference structures, low infundibulum demonstrated the highest values on both pre- and post-contrast imaging. Muscle resulted in high agreement on pre-contrast images but poor agreement post-contrast. Normal vessel demonstrated poor agreement on pre-contrast measurements but good agreement on post-contrast images.

Table 3:

Plaque and Reference Signal Measurement

Pre-Cortrast Signal Measurements Post-Contrast Signal Measurements
Structure Mean Std Dev Std Error ICC Mear Std Dev Std Error ICC
Plaque (n=54) 162.5 42.0 17.1 0.451 366.4 111.0 45.3 0.920
Normal Vessel (n=54) 112.5 27.9 11.4 0.463 126.2 33.9 13.8 0.819
Mid Infundibulum (n=49) 159.9 32.0 13.1 0.491 266.1 65.4 26.7 0.478
Low Infundibulum (n=44) 160.3 38.1 15.6 0.798 275.9 71.4 29.1 0.782
Choroid Plexus (n=54) 157.4 38.9 15.9 0.477 280.2 79.9 32.6 0.574
Cavernous Sinus (n=52) 138.4 38.2 15.6 0.492 371.9 95.1 38.8 0.370
Muscle (n=54) 99.8 45.3 18.5 0.760 134.5 29.2 11.9 0.275

Considering MRI intensity recorded by raters, agreement for mean pre-contrast plaque signal was moderate (ICC=0.451). Mean post-contrast signal for plaques demonstrated excellent inter-rater agreement (ICC=0.920). When assessing the mean difference between post- and pre-contrast signal, excellent agreement was again observed (ICC=0.820). Assessing plaque enhancement irrespective of reference structures, the highest degree of agreement with binary qualitative assessment was found with a threshold of 80% increase in signal, yielding moderate agreement (κ=0.466). Among quantitative assessment using a normally-enhancing reference structure, the ratio of plaque enhancement to low infundibulum enhancement demonstrated the highest agreement with qualitative assessment. A ratio of 0.8 for this measure resulted in κ=0.675. The next highest value was noted for a ratio of 0.3 of plaque enhancement to muscle enhancement (κ=0.547). Cohen’s kappa values were lower for agreement between qualitative assessment and quantitative analysis utilizing the remaining reference structures. Representative agreement values are summarized in Table 4.

Table 4:

Cohen’s Kappa Values for Various Plaque and Reference Enhancement Ratios

0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5
Plaque Intrinsic 0.151 0.291 0.438 0.438 0.438 0.466 0.328 0.255 0.256 0.209 0.148 0.086 0.065
Normal Vessel 0.312 0.312 0.312 0.312 0.312 0.312 0.312 0.312 0.312 0.312 0.245 0.245 0.193
Low Infundibulum 0.338 0.493 0.493 0.493 0.493 0.675 0.569 0.450 0.388 0.239 0.195 0.170 0.159
Mid Infundibulum 0.117 0.350 0.350 0.350 0.314 0.282 0.282 0.328 0.301 0.337 0.274 0.224 0.182
Choroid 0.245 0.193 0.338 0.438 0.391 0.466 0.425 0.357 0.277 0.235 0.293 0.293 0.224
Cavernous Sinus 0.438 0.389 0.328 0.168 0.080 0.035 0.023 0.053 0.047 0.047 0.031 0.031 0.026
Muscle 0.547 0.462 0.394 0.394 0.493 0.493 0.493 0.438 0.512 0.425 0.425 0.357 0.357

DISCUSSION

Imaging options and understanding of ICAD have expanded with the advent of vwMRI techniques.[16,2,3,1] To better facilitate widespread clinical acceptance, standardization of techniques and interpretation are needed. Lesion enhancement in particular is subject to heterogeneity among evaluators.[715] The current study was undertaken to compare qualitative rating of enhancement against quantitative techniques in an attempt to better bridge current VWI evaluation with more objective methods.

Among features assessed on vwMRI, plaque enhancement is particularly problematic with respect to variability among institutions using vwMRI and the raters interpreting these studies. Among previously published investigations of enhancement characteristics, a wide variety of techniques have been reported. Some use strictly qualitative methods, while others employ semi-quantitative techniques, and others offer no description of the methods for determining enhancement.[715] Additionally, some techniques assess enhancement against the vessel itself, while others assess enhancement with respect to non-vascular structures, including those that normally enhance and others that do not.[715] An additional source of heterogeneity lies in the variable characterization of vessel wall enhancement. Certain investigations characterize enhancement in a binary fashion while others qualitatively or semi-quantitatively assign degree of enhancement according to an ordinal scale.[715] This study does not seek to assess superiority among the previously reported interpretation methods. Rather, to better harmonize understanding of ICAD enhancement on future vwMRI studies, this study seeks to compare the qualitative binary approach previously used by our group against quantitative metrics, some of which are similar to previously reported methods.

Assessment of plaque enhancement can be augmented by comparison against normal structures, a practice that has gained acceptance in evaluation of the extracranial carotids with vwMRI.[28,29] Most brain structures do not enhance following administration of gadolinium due to exclusion of the contrast material by the blood-brain barrier.[25] The arterial vessel walls are among such normally non-enhancing structures; although normal intracranial arteries lack vasa vasorum, minimal enhancement sometimes visualized may reflect some baseline intimal permeability.[30] A small number of intracranial structures are not subject to contrast exclusion by the blood-brain barrier and enhance normally.[25] These structures can be taken advantage of to assess the degree of normal enhancement above background.

Previous investigations of vessel wall enhancement on vwMRI have mostly used qualitative comparison between pre- and post-contrast of the area of interest or comparison against various structures.[715] Many studies describe no methodology for comparison against reference control structures.[7,8,13] Various investigations have utilized non-enhancing tissues subject to the blood-brain barrier like gray matter, ventricles, or normal vessel segments.[9,15,11,14] In the current study of multiple enhancing structures, muscle showed the weakest enhancement. Muscle has been utilized in prior studies, at times using lesion enhancement greater than 150% of pre-contrast muscle signal as the threshold for determining enhancement.[31,13] In this study, quantitative assessment using the temporalis muscle as a reference yielded the second highest agreement with the binary qualitative assessment. Others have compared enhancement against the pituitary gland or its infundibulum, several accounting for its robust enhancement by using these structures as thresholds for “strong” enhancement.[9,10,12] This is consistent with greater enhancement seen in the infundibulum compared to muscle in the current study.

In addition to variability in methods among previously reported investigative groups, heterogeneity can also exist within studies between raters. In this study, inter-rater variability was measured to assess different reference structures. Measurements of the low infundibulum had the highest inter-rater agreement on both pre- and post-contrast images. Muscle demonstrated high agreement pre-contrast measurements but poor agreement post-contrast measurements, while normal vessel segments demonstrated poor agreement on pre-contrast measurements and high agreement on post-contrast measurements. Mid infundibulum, choroid plexus, and cavernous sinus measurements had inferior agreeability on both pre- and post-contrast imaging.

The previous method of enhancement evaluation employed by our group, qualitatively assessing a binary rating of presence or absence of enhancement, including subjective comparison against the infundibulum, demonstrated good inter-rater agreement with κ=0.783. However, agreement within our group does not necessarily lend to agreement with raters trained differently or with potentially conflicting interpretative tendencies. As such, we sought to compare our qualitative approach against several quantitative metrics. The quantitative measure showing the most agreement with this qualitative binary assessment was a ratio of lesion enhancement to enhancement of the low infundibulum. A threshold of 0.8 for a ratio of these two measures resulted in κ=0.675. This demonstrated superior agreement with the qualitative binary method compared to agreement between the qualitative method and enhancement without comparison to a reference structure. Additional metrics demonstrated much lower values for Cohen’s kappa.

To our knowledge, the current study is the first to assess quantitative evaluation of enhancement against a previously utilized qualitative metric. The methods demonstrating good agreement, specifically a ratio of 0.8 of plaque enhancement to low infundibulum enhancement, are easily performed and reproducible. If low infundibulum is excluded from view, comparison against the temporalis muscle can be reliably used as well, with a ratio of 0.3 optimum for agreement with the qualitative technique. We advocate for adoption of such techniques in future vwMRI studies so that more uniform evaluation can be conducted to promote consistency in the field. vwMRI studies of ICAD should utilize such quantitative metrics to reliably assess this disease in a way to reproducibly identify which lesions are likely to cause strokes. Better metrics, such as those described above, can in turn lead to more refined treatment algorithms to improve patient outcomes.

This study contains several limitations that warrant discussion. While it elucidates how certain quantitative techniques relate to previously used qualitative assessment, further investigation is needed to understand exactly what enhancement represents physiologically so that it can better inform clinical understanding. Retrospective studies such as this can introduce bias despite the prospective acquisition of their data. Additionally, selection bias may exist in the examined cohort, which only includes patients with confirmed culprit ICAD. Further evaluation is needed to assess ICAD lesions against normal vessels, as well as comparison between symptomatic and asymptomatic lesions, to assess what features cause certain lesions to result in strokes while other plaques remain quiescent.

Additionally, there are current limitations of vwMRI studies in general as currently constituted. Enhancement depends on T1 values and on the T1-weighting of a given sequence, which in turn can be affected by the flip angle and the refocusing angle. While such factors that can affect image readout were controlled for in the present study by utilizing the same protocol on all patients, differences among protocols across different centers can lead to heterogeneity. Such considerations related to this study’s limitations and current factors limiting vwMRI writ large must be incorporated into future research, ideally incorporating quantitative metrics such as those described above to better achieve reproducible results.

CONCLUSION

Quantitative techniques are needed to better standardize investigation of arterial enhancement with vwMRI for the evaluation of ICAD. As part of such an approach, plaque enhancement can be compared against background structures. In this study, measurements of the low infundibulum had the highest inter-rater agreement on both pre- and post-contrast images. Incorporating this standard, the quantitative approach described in these methods demonstrates high inter-rater agreement that corresponds well to previously utilized qualitative binary assessment of enhancmeent. Such reproducible quantitative techniques warrant further investigation and should be implemented in future research of vwMRI for the evaluation of ICAD.

Figure 3.

Figure 3.

Graphical representation of Cohen’s Kappa values for ratios of signal measurements of plaque over various reference structures.

Acknowledgments

Funding—No funding was received for this study.

Footnotes

Conflict of interest—The authors declare that they have no conflict of interest.

Ethical approval—All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent—Informed consent was obtained from all individual participants included in the study.

Contributor Information

Matthew D. Alexander, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah Department of Neurosurgery, University of Utah, Salt Lake City, Utah.

Adam de Havenon, Department of Neurology, University of Utah, Salt Lake City, Utah.

Seong-Eun Kim, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah.

Dennis L. Parker, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah

Joseph S. McNally, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah

REFERENCES

  • 1.Mossa-Basha M, Alexander M, Gaddikeri S, Yuan C, Gandhi D (2016) Vessel wall imaging for intracranial vascular disease evaluation. J Neurointerv Surg 8 (11):1154–1159. doi: 10.1136/neurintsurg-2015-012127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.de Havenon A, Mossa-Basha M, Shah L, Kim SE, Park M, Parker D, McNally JS (2017) High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease. Neuroradiology 59 (12):1193–1202. doi: 10.1007/s00234-017-1925-9 [DOI] [PubMed] [Google Scholar]
  • 3.Mandell DM, Mossa-Basha M, Qiao Y, Hess CP, Hui F, Matouk C, Johnson MH, Daemen MJ, Vossough A, Edjlali M, Saloner D, Ansari SA, Wasserman BA, Mikulis DJ, Vessel Wall Imaging Study Group of the American Society of N (2017) Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR American journal of neuroradiology 38 (2):218–229. doi: 10.3174/ajnr.A4893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cogswell PM, Siero JCW, Lants SK, Waddle S, Davis LT, Gilbert G, Hendrikse J, Donahue MJ (2018) Variable impact of CSF flow suppression on quantitative 3.0T intracranial vessel wall measurements. J Magn Reson Imaging 48 (4):1120–1128. doi: 10.1002/jmri.26028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Li L, Chai JT, Biasiolli L, Robson MD, Choudhury RP, Handa AI, Near J, Jezzard P (2014) Black-blood multicontrast imaging of carotid arteries with DANTE-prepared 2D and 3D MR imaging. Radiology 273 (2):560–569. doi: 10.1148/radiol.14131717 [DOI] [PubMed] [Google Scholar]
  • 6.Li L, Miller KL, Jezzard P (2012) DANTE-prepared pulse trains: a novel approach to motion-sensitized and motion-suppressed quantitative magnetic resonance imaging. Magn Reson Med 68 (5):1423–1438. doi: 10.1002/mrm.24142 [DOI] [PubMed] [Google Scholar]
  • 7.Gupta A, Baradaran H, Al-Dasuqi K, Knight-Greenfield A, Giambrone AE, Delgado D, Wright D, Teng Z, Min JK, Navi BB, Iadecola C, Kamel H (2016) Gadolinium Enhancement in Intracranial Atherosclerotic Plaque and Ischemic Stroke: A Systematic Review and Meta-Analysis. J Am Heart Assoc 5 (8). doi: 10.1161/JAHA.116.003816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kim JM, Jung KH, Sohn CH, Moon J, Han MH, Roh JK (2012) Middle cerebral artery plaque and prediction of the infarction pattern. Arch Neurol 69 (11):1470–1475. doi: 10.1001/archneurol.2012.1018 [DOI] [PubMed] [Google Scholar]
  • 9.Qiao Y, Zeiler SR, Mirbagheri S, Leigh R, Urrutia V, Wityk R, Wasserman BA (2014) Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. Radiology 271 (2):534–542. doi: 10.1148/radiol.13122812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Skarpathiotakis M, Mandell DM, Swartz RH, Tomlinson G, Mikulis DJ (2013) Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. AJNR American journal of neuroradiology 34 (2):299–304. doi: 10.3174/ajnr.A3209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vakil P, Vranic J, Hurley MC, Bernstein RA, Korutz AW, Habib A, Shaibani A, Dehkordi FH, Carroll TJ, Ansari SA (2013) T1 gadolinium enhancement of intracranial atherosclerotic plaques associated with symptomatic ischemic presentations. AJNR American journal of neuroradiology 34 (12):2252–2258. doi: 10.3174/ajnr.A3606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.van der Kolk AG, Zwanenburg JJ, Brundel M, Biessels GJ, Visser F, Luijten PR, Hendrikse J (2011) Intracranial vessel wall imaging at 7.0-T MRI. Stroke; a journal of cerebral circulation 42 (9):2478–2484. doi: 10.1161/STROKEAHA.111.620443 [DOI] [PubMed] [Google Scholar]
  • 13.Xu P, Lv L, Li S, Ge H, Rong Y, Hu C, Xu K (2015) Use of high-resolution 3.0-T magnetic resonance imaging to characterize atherosclerotic plaques in patients with cerebral infarction. Exp Ther Med 10 (6):2424–2428. doi: 10.3892/etm.2015.2815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zou XD, Chung YC, Zhang L, Han Y, Yang Q, Jia J (2015) Middle Cerebral Artery Atherosclerotic Plaques in Recent Small Subcortical Infarction: A Three-Dimensional High-resolution MR Study. Biomed Res Int 2015:540217. doi: 10.1155/2015/540217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Teng Z, Peng W, Zhan Q, Zhang X, Liu Q, Chen S, Tian X, Chen L, Brown AJ, Graves MJ, Gillard JH, Lu J (2016) An assessment on the incremental value of high-resolution magnetic resonance imaging to identify culprit plaques in atherosclerotic disease of the middle cerebral artery. Eur Radiol 26 (7):2206–2214. doi: 10.1007/s00330-015-4008-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Alexander MD, Yuan C, Rutman A, Tirschwell DL, Palagallo G, Gandhi D, Sekhar LN, Mossa-Basha M (2016) High-resolution intracranial vessel wall imaging: imaging beyond the lumen. J Neurol Neurosurg Psychiatry 87 (6):589–597. doi: 10.1136/jnnp-2015-312020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chen XY, Wong KS, Lam WW, Zhao HL, Ng HK (2008) Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 25 (1–2):74–80. doi: 10.1159/000111525 [DOI] [PubMed] [Google Scholar]
  • 18.Kerwin WS, Oikawa M, Yuan C, Jarvik GP, Hatsukami TS (2008) MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 59 (3):507–514. doi: 10.1002/mrm.21532 [DOI] [PubMed] [Google Scholar]
  • 19.Qiao Y, Etesami M, Astor BC, Zeiler SR, Trout HH 3rd, Wasserman BA (2012) Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. AJNR American journal of neuroradiology 33 (4):755–760. doi: 10.3174/ajnr.A2863 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, Butany J, Wasserman BA, Johnstone DM, Silver FL, Mikulis DJ (2009) Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology 72 (7):627–634. doi: 10.1212/01.wnl.0000342470.69739.b3 [DOI] [PubMed] [Google Scholar]
  • 21.Vergouwen MD, Silver FL, Mandell DM, Mikulis DJ, Swartz RH (2011) Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol 68 (3):338–342. doi: 10.1001/archneurol.2011.20 [DOI] [PubMed] [Google Scholar]
  • 22.Wasserman BA, Smith WI, Trout HH 3rd, Cannon RO 3rd, Balaban RS, Arai AE (2002) Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 223 (2):566–573. doi: 10.1148/radiol.2232010659 [DOI] [PubMed] [Google Scholar]
  • 23.Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, Hatsukami TS (2002) Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 15 (1):62–67 [DOI] [PubMed] [Google Scholar]
  • 24.Xu WH, Li ML, Gao S, Ni J, Yao M, Zhou LX, Peng B, Feng F, Jin ZY, Cui LY (2012) Middle cerebral artery intraplaque hemorrhage: prevalence and clinical relevance. Annals of neurology 71 (2):195–198. doi: 10.1002/ana.22626 [DOI] [PubMed] [Google Scholar]
  • 25.Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW (2007) Patterns of contrast enhancement in the brain and meninges. Radiographics 27 (2):525–551. doi: 10.1148/rg.272065155 [DOI] [PubMed] [Google Scholar]
  • 26.Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR American journal of neuroradiology 21 (4):643–646 [PMC free article] [PubMed] [Google Scholar]
  • 27.Warfarin-Aspirin Symptomatic Intracranial Disease Trial I (2003) Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 22 (2):106–117. doi: 10.1159/000068744 [DOI] [PubMed] [Google Scholar]
  • 28.McNally JS, McLaughlin MS, Hinckley PJ, Treiman SM, Stoddard GJ, Parker DL, Treiman GS (2015) Intraluminal thrombus, intraplaque hemorrhage, plaque thickness, and current smoking optimally predict carotid stroke. Stroke; a journal of cerebral circulation 46 (1):84–90. doi: 10.1161/STROKEAHA.114.006286 [DOI] [PubMed] [Google Scholar]
  • 29.Yamada N, Higashi M, Otsubo R, Sakuma T, Oyama N, Tanaka R, Iihara K, Naritomi H, Minematsu K, Naito H (2007) Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR American journal of neuroradiology 28 (2):287–292 [PMC free article] [PubMed] [Google Scholar]
  • 30.Portanova A, Hakakian N, Mikulis DJ, Virmani R, Abdalla WM, Wasserman BA (2013) Intracranial vasa vasorum: insights and implications for imaging. Radiology 267 (3):667–679. doi: 10.1148/radiol.13112310 [DOI] [PubMed] [Google Scholar]
  • 31.Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI (2011) Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging 21 (2):e159–161. doi: 10.1111/j.1552-6569.2009.00442.x [DOI] [PubMed] [Google Scholar]

RESOURCES